ATE382681T1 - Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen - Google Patents

Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen

Info

Publication number
ATE382681T1
ATE382681T1 AT99941984T AT99941984T ATE382681T1 AT E382681 T1 ATE382681 T1 AT E382681T1 AT 99941984 T AT99941984 T AT 99941984T AT 99941984 T AT99941984 T AT 99941984T AT E382681 T1 ATE382681 T1 AT E382681T1
Authority
AT
Austria
Prior art keywords
stem cells
mesenchymal stem
transplantation
heart function
improved heart
Prior art date
Application number
AT99941984T
Other languages
English (en)
Inventor
Donald Mickle
Ren-Ke Le
Richard Weisel
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE382681T1 publication Critical patent/ATE382681T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1329—Cardiomyocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99941984T 1998-07-31 1999-07-29 Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen ATE382681T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9479498P 1998-07-31 1998-07-31
US12915299P 1999-04-14 1999-04-14

Publications (1)

Publication Number Publication Date
ATE382681T1 true ATE382681T1 (de) 2008-01-15

Family

ID=26789238

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99941984T ATE382681T1 (de) 1998-07-31 1999-07-29 Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen

Country Status (9)

Country Link
US (1) US20050031600A1 (de)
EP (1) EP1100870B1 (de)
JP (1) JP2002521493A (de)
AT (1) ATE382681T1 (de)
AU (1) AU5545499A (de)
BR (1) BR9912662A (de)
CA (1) CA2339182C (de)
DE (1) DE69937888T2 (de)
WO (1) WO2000006701A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030103951A1 (en) * 1997-07-14 2003-06-05 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
US20040131601A1 (en) * 2000-03-30 2004-07-08 Foundry Networks, Inc., A Delaward Corporation Injection of bone marrow-derived cells and medium for angiogenesis
US7097832B1 (en) * 1999-03-30 2006-08-29 Myocardial Therapeutics, Inc. Intramyocardial injection of autologous bone marrow
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AU2695000A (en) * 1999-12-28 2001-07-09 Kyowa Hakko Kogyo Co. Ltd. Adult bone marrow-origin cell capable of differentiating into heart muscle cell
WO2001048150A1 (fr) * 1999-12-28 2001-07-05 Kyowa Hakko Kogyo Co., Ltd. Cellules pouvant se differencier en cellules du muscle cardiaque
WO2002008389A2 (en) * 2000-07-26 2002-01-31 Scimed Life Systems, Inc. Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002013760A2 (en) * 2000-07-31 2002-02-21 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
CN1543500B (zh) 2001-07-12 2014-04-09 杰龙公司 从人多能干细胞产生心肌细胞系细胞
US7732199B2 (en) 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
US20030082153A1 (en) 2001-10-22 2003-05-01 The Government Of The United States Of America Stem cells that transform to beating cardiomyocytes
US7998062B2 (en) 2004-03-29 2011-08-16 Superdimension, Ltd. Endoscope structures and techniques for navigating to a target in branched structure
CA2493768A1 (en) * 2002-07-23 2004-01-29 Nanodiagnostics, Inc. Embryonic stem cell markers and uses thereof
WO2007116408A2 (en) * 2006-04-11 2007-10-18 Nanodiagnostics Israel Ltd. Pluripotent stem cells characterized by expression of germline specific genes
AR047712A1 (es) * 2002-09-07 2006-02-15 Royal Veterinary College Metodo de tratamiento de una lesion de tejido esqueletico blando natural administrando una composicion de celulas madre mesenquimatosas
WO2004045666A1 (ja) * 2002-11-15 2004-06-03 Kyushu Tlo Company, Limited. 臓器の再生方法
US20070053839A1 (en) * 2003-06-12 2007-03-08 Jianyi Zhang Directing cells to target tissues organs
EP2316328B1 (de) 2003-09-15 2012-05-09 Super Dimension Ltd. Umhüllungsvorrichtung zur Fixierung von Bronchoskopen
ES2387026T3 (es) 2003-09-15 2012-09-11 Super Dimension Ltd. Dispositivo de fijación envolvente para utilizarse con broncoscopios
WO2005028872A2 (en) 2003-09-18 2005-03-31 Myrakelle, Llc Rotary blood pump
AU2003286416A1 (en) * 2003-12-04 2005-06-24 Dr. Ravi Agarwal A novel process and method for deriving cardiomyocyte precursors from bone-marrow stem cells
EP1544290A1 (de) * 2003-12-19 2005-06-22 Yu-Show Fu System zur Herstellung somatischer Zellen
US8764725B2 (en) 2004-02-09 2014-07-01 Covidien Lp Directional anchoring mechanism, method and applications thereof
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
EP2298862B1 (de) * 2004-03-22 2017-08-30 Mesoblast International Sàrl Mesenchymale Stammzellen und deren Verwendungen
US7452718B2 (en) 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
US20050233443A1 (en) * 2004-03-30 2005-10-20 Toby Freyman Restenosis therapy using mesenchymal stem cells
RU2006147263A (ru) * 2004-06-08 2008-07-20 ПРАЙМДЖЕН БАЙОТЕК ЭлЭлСи (US) Терапевтическое перепрограммирование, гибридные стволовые клетки и созревание
US20050277124A1 (en) 2004-06-10 2005-12-15 White Steven M Cardiac conduction system cells and uses thereof
KR20130100225A (ko) 2004-09-24 2013-09-09 안지오블라스트 시스템스 인코퍼레이티드 간엽 전구세포의 증식 및/또는 생존성 증강 방법
WO2006060382A2 (en) * 2004-11-30 2006-06-08 Trustees Of The University Of Pennsylvania Use of hdac and/or dnmt inhibitors for treatment of ischemic injury
US9062289B2 (en) 2005-06-22 2015-06-23 Asterias Biotherapeutics, Inc. Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
CN101932837A (zh) 2006-03-31 2010-12-29 索罗泰克公司 旋转式血泵
WO2008125279A2 (en) * 2007-04-11 2008-10-23 Universitätsklinikum Heidelberg Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells
WO2008132722A1 (en) * 2007-04-26 2008-11-06 Ramot At Tel-Aviv University Ltd. Pluripotent autologous stem cells from oral mucosa and methods of use
US8905920B2 (en) 2007-09-27 2014-12-09 Covidien Lp Bronchoscope adapter and method
WO2009046058A1 (en) * 2007-10-01 2009-04-09 University Of Miami A method to amplify cardiac stem cells in vitro and in vivo
US9962409B2 (en) 2007-10-01 2018-05-08 Vestion, Inc. Therapy using cardiac stem cells and mesenchymal stem cells
EP2219656A2 (de) 2007-11-09 2010-08-25 New York Medical College Verfahren zur reparatur und/oder regeneration von geschädigtem myokard mit varianten des hepatozyten-wachstumsfaktors
CA2712891A1 (en) 2008-01-30 2009-08-06 Corning Incorporated Synthetic surfaces for culturing stem cell derived cardiomyocytes
US9575140B2 (en) 2008-04-03 2017-02-21 Covidien Lp Magnetic interference detection system and method
EP2297673B1 (de) 2008-06-03 2020-04-22 Covidien LP Registrationsverfahren auf merkmalbasis
US8218847B2 (en) 2008-06-06 2012-07-10 Superdimension, Ltd. Hybrid registration method
US8932207B2 (en) 2008-07-10 2015-01-13 Covidien Lp Integrated multi-functional endoscopic tool
US8611984B2 (en) 2009-04-08 2013-12-17 Covidien Lp Locatable catheter
WO2011159834A1 (en) 2010-06-15 2011-12-22 Superdimension, Ltd. Locatable expandable working channel and method
WO2013120577A1 (en) 2012-02-14 2013-08-22 Merck Patent Gmbh Spirobifluorene compounds for organic electroluminescent devices
WO2014027474A1 (ja) * 2012-08-17 2014-02-20 株式会社Ｃｌｉｏ 心筋梗塞の修復再生を誘導する多能性幹細胞
ES2824165T3 (es) 2012-11-30 2021-05-11 Vestion Inc Células madre cardíacas y métodos de identificación y uso de las mismas
JP2016537414A (ja) 2013-10-29 2016-12-01 ベスティオン、インク． 心臓神経堤細胞、及びその使用方法
US9402549B2 (en) 2013-11-27 2016-08-02 General Electric Company Methods and apparatus to estimate ventricular volumes
DK3083671T3 (da) 2013-12-20 2020-12-07 Hutchinson Fred Cancer Res Mærkede kimære effektormolekyler og receptorer deraf
US10952593B2 (en) 2014-06-10 2021-03-23 Covidien Lp Bronchoscope adapter
US10918669B2 (en) 2014-07-25 2021-02-16 Recellerate, Inc. Methods of treating exercise-induced pulmonary hemorrhage
US11827904B2 (en) 2015-04-29 2023-11-28 Fred Hutchinson Cancer Center Modified stem cells and uses thereof
US10426555B2 (en) 2015-06-03 2019-10-01 Covidien Lp Medical instrument with sensor for use in a system and method for electromagnetic navigation
US10478254B2 (en) 2016-05-16 2019-11-19 Covidien Lp System and method to access lung tissue
CN106038597B (zh) * 2016-05-27 2020-01-31 遵义医学院附属医院 间充质干细胞在制备治疗急性肺损伤制剂中的应用
US10517505B2 (en) 2016-10-28 2019-12-31 Covidien Lp Systems, methods, and computer-readable media for optimizing an electromagnetic navigation system
US10418705B2 (en) 2016-10-28 2019-09-17 Covidien Lp Electromagnetic navigation antenna assembly and electromagnetic navigation system including the same
US10792106B2 (en) 2016-10-28 2020-10-06 Covidien Lp System for calibrating an electromagnetic navigation system
US10638952B2 (en) 2016-10-28 2020-05-05 Covidien Lp Methods, systems, and computer-readable media for calibrating an electromagnetic navigation system
US10722311B2 (en) 2016-10-28 2020-07-28 Covidien Lp System and method for identifying a location and/or an orientation of an electromagnetic sensor based on a map
US10615500B2 (en) 2016-10-28 2020-04-07 Covidien Lp System and method for designing electromagnetic navigation antenna assemblies
US10751126B2 (en) 2016-10-28 2020-08-25 Covidien Lp System and method for generating a map for electromagnetic navigation
US10446931B2 (en) 2016-10-28 2019-10-15 Covidien Lp Electromagnetic navigation antenna assembly and electromagnetic navigation system including the same
US11219489B2 (en) 2017-10-31 2022-01-11 Covidien Lp Devices and systems for providing sensors in parallel with medical tools

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963489A (en) * 1987-04-14 1990-10-16 Marrow-Tech, Inc. Three-dimensional cell and tissue culture system
US5202120A (en) * 1987-09-11 1993-04-13 Case Western Reserve University Methods of reducing glial scar formation and promoting axon and blood vessel growth and/or regeneration through the use of activated immature astrocytes
US5197985A (en) * 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5486359A (en) * 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5226914A (en) * 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
CA2111347A1 (en) * 1991-06-12 1992-12-23 David A. Smith Method for inducing human myocardial cell proliferation
US5543318A (en) * 1991-06-12 1996-08-06 Smith; David A. Method of isolation, culture and proliferation of human atrial myocytes
WO1994000484A1 (en) * 1992-06-22 1994-01-06 Young Henry E Scar inhibitory factor and use thereof
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US5736396A (en) * 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
AU706026B2 (en) * 1995-06-06 1999-06-10 Case Western Reserve University Myogenic differentiation of human mesenchymal stem cells
JP3781433B2 (ja) * 1995-11-16 2006-05-31 ケース ウエスターン リザーブ ユニバーシティ ヒト間葉幹細胞の試験管内軟骨形成誘導
JP2000508922A (ja) * 1996-04-26 2000-07-18 ケース ウエスターン リザーブ ユニバーシティ 間葉幹細胞を用いる皮膚再生
US6110459A (en) * 1997-05-28 2000-08-29 Mickle; Donald A. G. Transplants for myocardial scars and methods and cellular preparations
US6099832A (en) * 1997-05-28 2000-08-08 Genzyme Corporation Transplants for myocardial scars
DE69831957T3 (de) * 1997-07-14 2009-07-23 Osiris Therapeutics, Inc. Herzmuskelregenerierung unter verwendung mesenchymaler stammzellen
CA2324350A1 (en) * 1998-03-23 1999-09-30 Zymogenetics, Inc. Cardiac-derived stem cells
WO2001007568A2 (en) * 1999-07-23 2001-02-01 Diacrin, Inc. Muscle cells and their use in cardiac repair

Also Published As

Publication number Publication date
CA2339182A1 (en) 2000-02-10
AU5545499A (en) 2000-02-21
EP1100870A4 (de) 2004-10-13
JP2002521493A (ja) 2002-07-16
CA2339182C (en) 2010-04-06
WO2000006701A9 (en) 2000-06-15
US20050031600A1 (en) 2005-02-10
BR9912662A (pt) 2001-06-05
DE69937888D1 (de) 2008-02-14
EP1100870A1 (de) 2001-05-23
EP1100870B1 (de) 2008-01-02
WO2000006701A1 (en) 2000-02-10
DE69937888T2 (de) 2009-01-02

Similar Documents

Publication Publication Date Title
ATE382681T1 (de) Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
ATE328067T1 (de) Isolierung von mesenchymalen stammzellen und deren verwendung
WO2003080801A3 (en) Adipose stromal stem cells for tissue and vascular modification
DE69934407D1 (de) Leberstammzellen
NO20021281L (no) Vaskul¶r beleggingssammensetning
EA200300738A1 (ru) Защита, восстановление и усиление эритропоэтинреактивных клеток, тканей и органов
DK1226233T3 (da) Multipotente voksne stamceller og fremgangsmåder til isolering heraf
DE69916792D1 (de) Kaliumkanalblocker
WO2000001231A3 (en) Improved methods for storing neural cells
MXPA02007137A (es) Fuente de tejido hepatico.
IS5856A (is) Aðferðir þar sem integrín-mótlyf eru notuð til aðmeðhöndla margföld mergæxli og uppsog í bein af völdum mergæxla
EA200001129A2 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
NO2019032I1 (no) Treosulfan
ATE305785T1 (de) Cd45 hemmer
ATE324905T1 (de) Verwendung von plgf zur vorbeugung oder behandlung von ischaemie oder schlaganfall
MXPA02002444A (es) Metodo para generar celulas y tejidos inmunocompatibles, utilizando tecnicas de transferencia nuclear.
PL1664307T3 (pl) Nowy, specyficzny dla bielma promotor roślinny dla roślin uprawnych
ATE258443T1 (de) Verwendung des proteins uk 114 zur verhinderung der abstossung eines transplantierten organs
DK1261325T3 (da) Tumorinhiberende sammensætninger, der indeholder nitroacridiner
DE60225530D1 (de) Phosphorylierte glyoxalase i und deren verwendung
DE60203726D1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden
UA39614A (uk) Спосіб корекції функціонального стану міокарда у лабораторних тварин пізнього онтогенезу
UA33888A (uk) Спосіб зменшення імунореактивності алогенного кісткового мозку експериментальних тварин
BG102613A (en) New substituted imidazoles
AP2003002938A0 (en) Intermediates for making HIV- protease inhibitors and methods of making HIV protease inhibitors.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties